Vaccine reduces cervical-cancer virus' prevalence in teenage girls by almost 65%
Latest study may energise a tumultuous struggle in America to encourage HPV vaccination
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
New York
A VACCINE introduced a decade ago to combat the sexually transmitted virus that causes cervical cancer has already reduced the virus' prevalence in teenage girls by almost two-thirds, federal researchers said on Monday.
Even for women in their early 20s, a group with lower vaccination rates, the most dangerous strains of human papillomavirus (HPV) have still been reduced by more than a third.
Share with us your feedback on BT's products and services
TRENDING NOW
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
Beijing’s calculated silence on the Iran war
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
